NCT00527514View on ClinicalTrials.gov

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

185

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Hypertension

Interventions

DRUG

Amlodipine

Tablets

DRUG

Olmesartan medoxomil plus amlodipine

Tablets

Trial Locations (18)

Unknown

Buena Park

Long Beach

Los Angeles

Sacramento

Tustin

Westlake Village

Castle Rock

Pembroke Pines

Orland Park

Natick

New York

Winston-Salem

Cincinnati

Beaver

Greer

Carrolton

Corpus Christi

Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY